(Q41712607)

English

Systemic levels of free 5-aminosalicylic acid depend on the nature of the 5-aminosalicyclic acid derivative and not on disease activity or extent in patients with inflammatory bowel disease

scientific article published on October 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Systemic levels of free 5-aminosalicylic acid depend on the nature of the 5-aminosalicyclic acid derivative and not on disease activity or extent in patients with inflammatory bowel disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

inflammatory bowel diseases

1 reference

based on heuristic

inferred from title

author name string

Mahmud N

1

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Weir DG

2

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Kelleher D

3

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

publication date

1 October 1999

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Irish Journal of Medical Science

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

168

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

228-232

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

https://scigraph.springernature.com/pub.10.1007/bf02944345

0 references

An oral preparation to release drugs in the human colon

1 reference

https://api.crossref.org/works/10.1007%2FBF02944345

21 January 2018

Colonic release of 5-amino salicylic acid from an oral preparation in active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1007%2FBF02944345

21 January 2018

Measurement of gastrointestinal pH profiles in normal ambulant human subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Chronic interstitial nephritis after treatment with 5-aminosalicylic acid]

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism and urinary excretion of 5-amino salicylic acid in healthy volunteers when given intravenously or released for absorption at different sites in the gastrointestinal tract

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nephrotic syndrome after treatment with 5-aminosalicylic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sulphasalazine in ulcerative colitis: in memoriam?

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of massive doses of PAS on renal function and electrolyte balance

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salicylate-induced enzymuria: comparison with other anti-inflammatory agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glutathione transferase in the urine: a marker for post-transplant tubular lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nephrotic syndrome associated with sulphasalazine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An experiment to determine the active therapeutic moiety of sulphasalazine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of urinary N-acetyl-β-glucosaminidase in human renal toxicology II. Elevation in human excretion after aspirin and sodium salicylate

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Nephritis from 5-aminosalicylic acid]

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sulfasalazine. Adverse effects and desensitization

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mesalazine: an overview of key preclinical studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mesalazine induced interstitial nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-performance liquid chromatographic assay for the determination of 5-aminosalicylic acid and acetyl-5-aminosalicylic acid concentrations in endoscopic intestinal biopsy in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absorption and excretion of a single 1-g dose of azodisal sodium in subjects with ileostomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A simple index of Crohn's-disease activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics of olsalazine sodium in healthy volunteers after a single i.v. dose and after oral doses with and without food.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10624358

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF02944345

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41712607&oldid=1926210289"